{
    "Trade/Device Name(s)": [
        "BD Phoenix Automated Microbiology System Cefepime (0.0625-4 \u03bcg/mL)",
        "BD Phoenix Automated Microbiology System for use with the antimicrobial agent cefepime (0.0625-4 \u03bcg/mL) - Streptococcus ID/AST or AST only Phoenix Panels"
    ],
    "Submitter Information": "Becton, Dickinson and Company",
    "510(k) Number": "K051204",
    "Predicate Device Reference 510(k) Number(s)": [
        "N50510",
        "K020321",
        "K020323",
        "K020322"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "LON"
    ],
    "Summary Letter Date": "June 24, 2005",
    "Summary Letter Received Date": "May 11, 2005",
    "Submission Date": "May 9, 2005",
    "Regulation Number(s)": [
        "21 CFR 866.1645"
    ],
    "Regulation Name(s)": [
        "Fully Automated Short-Term Incubation Cycle Antimicrobial Susceptibility Devices"
    ],
    "Analyte Class(es)": [
        "microbiology"
    ],
    "Analyte(s)": [
        "Cefepime",
        "Streptococcus pneumoniae",
        "Streptococcus pyogenes",
        "Viridans group streptococci",
        "Streptococcus agalactiae"
    ],
    "Specimen Type(s)": [
        "Pure culture of most aerobic and facultative anaerobic Gram-negative and Gram-positive bacteria of human origin"
    ],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [
        "BD Phoenix Automated Microbiology System",
        "BD Phoenix instrument and software"
    ],
    "Method(s)/Technology(ies)": [
        "Broth based microdilution test",
        "Automated antimicrobial susceptibility testing",
        "Redox indicator for growth detection"
    ],
    "Methodologies": [
        "Antimicrobial susceptibility testing",
        "Minimal inhibitory concentration (MIC) determination",
        "Automated incubation and reading"
    ],
    "Submission Type(s)": [
        "System",
        "Panel",
        "Reagent"
    ],
    "Document Summary": "FDA 510(k) summary for BD Phoenix Automated Microbiology System Streptococcus ID/AST panels with cefepime for in vitro antimicrobial susceptibility testing.",
    "Indications for Use Summary": "Intended for in vitro quantitative determination of antimicrobial susceptibility by minimal inhibitory concentration (MIC) of Gram-negative and Gram-positive bacterial isolates including Streptococcus, Staphylococcus, and Enterococcus, using BD Phoenix Streptococcus panels containing cefepime.",
    "fda_folder": "Microbiology"
}